DaVita HealthCare Partners Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $95.51
- Today's High:
- $98.165
- Open Price:
- $95.88
- 52W Low:
- $65.28
- 52W High:
- $103
- Prev. Close:
- $96.26
- Volume:
- 1039783
Company Statistics
- Market Cap.:
- $8.99 billion
- Book Value:
- 9.106
- Revenue TTM:
- $11.67 billion
- Operating Margin TTM:
- 11.02%
- Gross Profit TTM:
- $3.40 billion
- Profit Margin:
- 4.41%
- Return on Assets TTM:
- 4.75%
- Return on Equity TTM:
- 30.37%
Company Profile
DaVita HealthCare Partners Inc had its IPO on 1995-10-31 under the ticker symbol DVA.
The company operates in the Healthcare sector and Medical Care Facilities industry. DaVita HealthCare Partners Inc has a staff strength of 70,000 employees.
Stock update
Shares of DaVita HealthCare Partners Inc opened at $95.88 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $95.51 - $98.17, and closed at $97.16.
This is a +0.94% increase from the previous day's closing price.
A total volume of 1,039,783 shares were traded at the close of the day’s session.
In the last one week, shares of DaVita HealthCare Partners Inc have slipped by -5.66%.
DaVita HealthCare Partners Inc's Key Ratios
DaVita HealthCare Partners Inc has a market cap of $8.99 billion, indicating a price to book ratio of 12.637 and a price to sales ratio of 0.5651.
In the last 12-months DaVita HealthCare Partners Inc’s revenue was $11.67 billion with a gross profit of $3.40 billion and an EBITDA of $2.02 billion. The EBITDA ratio measures DaVita HealthCare Partners Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, DaVita HealthCare Partners Inc’s operating margin was 11.02% while its return on assets stood at 4.75% with a return of equity of 30.37%.
In Q1, DaVita HealthCare Partners Inc’s quarterly earnings growth was a negative -22.4% while revenue growth was a positive 2%.
DaVita HealthCare Partners Inc’s PE and PEG Ratio
- Forward PE
- 8.8574
- Trailing PE
- 17.5816
- PEG
- 0.8622
Its diluted EPS in the last 12-months stands at $5.64 per share while it has a forward price to earnings multiple of 8.8574 and a PEG multiple of 0.8622. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into DaVita HealthCare Partners Inc’s profitability.
DaVita HealthCare Partners Inc stock is trading at a EV to sales ratio of 1.5748 and a EV to EBITDA ratio of 8.6175. Its price to sales ratio in the trailing 12-months stood at 0.5651.
DaVita HealthCare Partners Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $16.73 billion
- Total Liabilities
- $2.57 billion
- Operating Cash Flow
- $-116544000.00
- Capital Expenditure
- $147.71 million
- Dividend Payout Ratio
- 0%
DaVita HealthCare Partners Inc ended 2024 with $16.73 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $16.73 billion while shareholder equity stood at $825.47 million.
DaVita HealthCare Partners Inc ended 2024 with $771.09 million in deferred long-term liabilities, $2.57 billion in other current liabilities, 91000.00 in common stock, $290.03 million in retained earnings and $7.09 billion in goodwill. Its cash balance stood at $317.13 million and cash and short-term investments were $367.10 million. The company’s total short-term debt was $636,800,000 while long-term debt stood at $8.42 billion.
DaVita HealthCare Partners Inc’s total current assets stands at $3.04 billion while long-term investments were $286.27 million and short-term investments were $49.97 million. Its net receivables were $2.38 billion compared to accounts payable of $447.97 million and inventory worth $106.77 million.
In 2024, DaVita HealthCare Partners Inc's operating cash flow was $-116544000.00 while its capital expenditure stood at $147.71 million.
Comparatively, DaVita HealthCare Partners Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $97.16
- 52-Week High
- $103
- 52-Week Low
- $65.28
- Analyst Target Price
- $99.24
DaVita HealthCare Partners Inc stock is currently trading at $97.16 per share. It touched a 52-week high of $103 and a 52-week low of $103. Analysts tracking the stock have a 12-month average target price of $99.24.
Its 50-day moving average was $102.82 and 200-day moving average was $88.87 The short ratio stood at 3.93 indicating a short percent outstanding of 0%.
Around 322.5% of the company’s stock are held by insiders while 8863% are held by institutions.
Frequently Asked Questions About DaVita HealthCare Partners Inc
Similar Industry Stocks (Medical Care Facilities)
Most Active
Top Gainers
Top Losers
About
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.